MINNEAPOLIS, July 8 /PRNewswire-FirstCall/ -- Protectus Medical Devices, Inc. (OTCQB: PTMD), developer and marketer of innovative safety medical devices, announced today it has received Notice of Allowance from the US Patent and Trademark Office on its patent application describing a spring-activated, automatic, self-sheathing Safety Syringe, a major step toward it becoming the gold standard in safety syringe devices.
Dr. John Salstrom, CEO, said the unique spring-activation feature distinguishes the Protectus Safety Syringe and its entire line of safety needle devices from all others and, like no other, has the very real potential to significantly reduce accidental needlestick injuries automatically without any action by users.
Jack Dillard, COO and inventor of the Protectus/SquareOne Medical Safety Syringe and its family of safety needle devices, said, "The key elements of this patent provide coverage for the spring responsible for the automatic deployment of the Protectus safety technology that keeps users, patients and other healthcare workers safe during and after use without having to perform any conscience action."
Protectus also announced today the filing of its patent application for a Safety IV Catheter/Cannula Introducer. This device, along with the Protectus Safety Dental Syringe (patent application previously announced), both employ the same spring-activated safety features as the Protectus Safety Syringe, as does the soon-to-be announced Protectus Safety Phlebotomy device. All three devices will benefit significantly from the additional coverage provided by claims allowed in the new patent referenced by the above-mentioned Notice of Allowa